PYC pyc therapeutics limited

0.40%

$1.27

Thanks Wayne. As you know, I've had my attention on the BH3...

First 5 Last

Share
Profile

Follow
TonyIndo

11,715 Posts.

1543

19/04/17

21:30

Post #: 24152508
Share

Originally posted by waynesworld ↑

Thanks Rogues,
It was so intense that I was overwhelmed by the complexity of it all. At the beginning I thought that Bcl-2, p53 and Myc which are all involved in apoptosis were unrelated and could be targeted separately. By the end it appeared that tackling one target independently of Myc was like boxing with one hand tied behind your back.

I think that's why Doug Fairlie found that a combination of a Bcl-2 and Myc inhibitor improves the killing activity of each drug by up to 600% refer Phylogica announcement 09/12/2015. I think that's why Professor Sir David Lane is collaborating with Phylogica because despite decades of effort no drugs targeting the MDM2-p53 pathway have made it to market.

And I think that's why Dr Robert Hayes and Dr Rick Kendall have joined the Board of Directors. If all roads in cancer lead to Myc, as asserted by Dr Jay Bradner, then Phylogica with its iMyc candidates and FPP delivery system may find itself at the centre of universal Pharma attention.

Expand

Thanks Wayne.

As you know, I've had my attention on the BH3 mimetics class of drugs. Have a watch of this video, then refer to page 56 of Phylogica's presentation below re "Synergistic targeting of MYC and prosurvival proteins". Very interesting.

http://phylogica.com/wp-content/upl...ch-Showcase-San-Francisco-January-10-2017.pdf

Tony

PYC Price at posting: 3.8¢ Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

BOE

Boss extends June win streak with boosted Alta Mesa extraction rates

'Not possible' to port renewable gas: ACCC takes AGN to court

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

First 5 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.27		Change 0.005(0.40%)		Mkt cap ! $740.7M

Open	High	Low	Value	Volume
$1.27	$1.29	$1.27	$406.0K	319.3K

Buyers (Bids)

No.	Vol.	Price($)
1	13987	$1.27

Sellers (Offers)

Price($)	Vol.	No.
$1.29	1380	1

View Market Depth

No.	Vol.	Price($)
1	13987	1.265
2	16380	1.260
3	14380	1.255
3	103380	1.250
1	4000	1.225

Price($)	Vol.	No.
1.285	1380	1
1.290	27010	3
1.295	25880	2
1.300	59168	4
1.325	9001	1

Last trade - 16.10pm 27/06/2025 (20 minute delay)

PYC (ASX) Chart

Thanks Wayne. As you know, I've had my attention on the BH3...

Australia’s gas crisis is here – and dying coal plants aren’t helping

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Boss extends June win streak with boosted Alta Mesa extraction rates

'Not possible' to port renewable gas: ACCC takes AGN to court

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Thanks Wayne. As you know, I've had my attention on the BH3...

Top Stories

Australia’s gas crisis is here – and dying coal plants aren’t helping

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Boss extends June win streak with boosted Alta Mesa extraction rates

'Not possible' to port renewable gas: ACCC takes AGN to court

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News